No Summer Slump for CMS: Major Changes Proposed for the Medicare Shared Savings Program

September 6, 2018 Alerts and Newsletters

On August 17, 2018, the Centers for Medicare & Medicaid Services ("CMS") officially published a proposed rule ("Proposed Rule") in the Federal Register that would significantly alter the Medicare Shared Savings Program ("MSSP"). CMS is seeking to overhaul the MSSP due in part to the fact that, according to CMS, about 82% of the accountable care organizations ("ACOs") participating in the MSSP do not bear risk, and those ACOs have generally increased Medicare spending as compared to their cost benchmarks. The new direction for the MSSP under the Proposed Rule, which CMS refers to as "Pathways to Success," would, among other things, redesign the participation options available to ACOs, modify the MSSP benchmark methodology, and increase flexibility for ACOs. Below is a summary of some of the Proposed Rule's major provisions.

Participation Tracks

Probably the most significant change to the MSSP under the Proposed Rule is the accelerated transition to a two-sided risk model for all ACOs.

The MSSP currently offers ACOs three "Tracks," with each Track offering ACOs varying levels of risk and reward. ACOs participating in Track 1 experience no risk because they share only in their savings and not their losses, although there are limits to the length of time an ACO can participate in Track 1. This sort of arrangement—where only CMS bears risk and not the ACO—is referred to as a "one-sided" risk model. In contrast, ACOs participating in Tracks 2 and 3 can realize a greater percentage of their savings as compared to Track 1, but they also risk losses if their costs exceed their benchmarks. This latter arrangement is referred to as a "two-sided" risk model, because both CMS and the ACO bear risk. The vast majority of ACOs—82% in 2018—participate in Track 1.

The Proposed Rule seeks to accelerate ACOs' transition to a two-sided risk model by discontinuing the three Tracks and replacing them with a BASIC and ENHANCED track. Under the BASIC track, eligible ACOs would begin participating under a one-sided risk model for a maximum, in most cases, of two years, after which point the ACOs' levels of risk would increase annually. The ENHANCED track would be based on the MSSP's current Track 3 and would provide eligible ACOs with additional tools and flexibility for taking on the highest levels of risk and potential reward.

Application Periods

Under the Proposed Rule, CMS would not offer an application cycle in 2018 for new agreement periods beginning on January 1, 2019. Instead, CMS would offer an application cycle for a one-time new agreement period starting on July 1, 2019. ACOs with a participation agreement ending on December 31, 2018 would have the opportunity to extend their contracts another six months and apply for a new agreement starting on July 1, 2019.

Benchmarking Methodology

The Proposed Rule would alter the calculation for ACO benchmarks to improve their accuracy and predictability. By changing the regional trend and update factors, CMS seeks to produce more favorable trend factors for ACOs with high penetration regionally and lower spending growth as compared to the nation, and less favorable trend factors for ACOs with high penetration regionally and higher spending growth as compared to the nation. CMS would do this by increasing the weight of the national component of the blend of regional and national growth rates as an ACO's regional service area penetration increases. ACOs with low or moderate penetration regionally should see little effect from the changes to the regional trend and update factors.

Program Integrity

The Proposed Rule would implement a number of policies to strengthen the integrity of the MSSP and reduce gaming, including policies to evaluate prior participation by the ACO legal entity and its ACO participants in the MSSP (or similar programs) in the determination of MSSP participation options; more closely monitor the financial performance of ACOs and permit termination of poorly performing ACOs; and assess losses against ACOs that terminate in two-sided tracks.

Increased Flexibility

The Proposed Rule includes regulatory changes that seek to promote ACO innovation and care coordination. For example, ACOs would have greater choice of beneficiary assignment. Additionally, certain physicians and practitioners would have increased opportunities to receive payments for telehealth services, even where certain geographic limitations are not met. And the eligibility criteria for using the skilled nursing facility (SNF) 3-day rule would be expanded.

Beneficiary Engagement

The Proposed Rule seeks to promote increased beneficiary engagement by, among other changes, permitting ACOs to establish beneficiary incentive programs, strengthening requirements regarding beneficiary notifications to foster beneficiary choice, and permitting beneficiaries to designate physicians (regardless of specialty), nurse practitioners, physician assistants, or clinical nurse specialists as their primary clinician responsible for coordinating their overall care.

Verrill Dana's Health Care Group has been helping clients understand the implications of the Proposed Rule on their MSSP ACOs, as well as future options for participating in the MSSP. For further information on how Verrill Dana can assist with your questions regarding the Proposed Rule, please reach out to your regular Verrill Dana attorney.

___________________________________________________________________
This communication is intended for general information purposes and as a service to clients and friends of Verrill Dana, LLP. This publication, which may be considered advertising under the ethical rules of certain jurisdictions, should not be construed as legal advice or a legal opinion on any specific facts or circumstances, nor does it create attorney-client privilege.

Firm Highlights

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

Publication/Podcast

FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19

Prompted by a substantial increase in requests for individual patient access to investigational drugs and biologics to treat COVID-19, the U.S. Food & Drug Administration (“FDA”) issued guidance on June 2, 2020 that outlines...

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...

Publication/Podcast

FDA Updates its Guidance on Conducting Clinical Trials During COVID-19 Public Health Emergency

On April 16, 2020, the U.S. Food & Drug Administration (“FDA”) again updated its guidance on the “Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency,” adding seven new questions and...

Publication/Podcast

News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...

News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a...

News

Nearly 80 Verrill Attorneys Recognized by Best Lawyers® 2021, Including a Dozen Named Lawyers of the Year

(August 24, 2020) – Nearly 80 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2021 , including 12 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer...

Matter

Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Publication/Podcast

EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...

News

38 Verrill Attorneys, Across Four Offices, Recognized in 2020 Chambers & Partners Guide

(April 27, 2020) – Verrill has been rated as a Leading Firm in a total of ten categories and subcategories as evaluated by London-based Chambers & Partners , one of the world's most respected...